title: Expression of full-length human dystrophin cDNA in mdx mouse muscle by HVJ-liposome injection.
abstract: Duchenne muscular dystrophy (DMD) is an X-linked progressive muscle disorder which is caused by a defect of dystrophin, a 427-kDa muscle cell membrane protein. One of the possible means of DMD therapy is to express the dystrophin gene in patients' muscles. In this study, full length dystrophin cDNA was expressed in mdx (muscular dystrophy model) mouse muscle using the hemagglutinating virus of Japan (HVJ)-liposome method. With the HVJ-liposome method, the lacZ reporter genes were expressed in 50-80% of cultured mdx mouse myoblasts, which suggested its potential usefulness for an in vivo gene study. Three expression vectors containing human full length dystrophin cDNA driven by Rous sarcoma virus (RSV), mouse leukemia virus, or human dystrophin promoters, were used. HVJ-liposomes containing these plasmids were directly injected into mdx mouse quadriceps muscle. The highest efficiency of expression of dystrophin was in 26% of the muscle fibers at the injected site on day 3 after HVJ-liposome injection of the RSV-based vector. The expression was decreased on day 10. The study thus demonstrates the feasibility of full length human dystrophin cDNA transfer and dystrophin expression using HVJ-liposomes in vivo.
authors.affiliation: Department of Pediatrics, Osaka University, Faculty of Medicine, Japan.
authors.forename: I
authors.initials: I
authors.lastname: Yanagihara
authors.forename: K
authors.initials: K
authors.lastname: Inui
authors.forename: G
authors.initials: G
authors.lastname: Dickson
authors.forename: G
authors.initials: G
authors.lastname: Turner
authors.forename: T
authors.initials: T
authors.lastname: Piper
authors.forename: Y
authors.initials: Y
authors.lastname: Kaneda
authors.forename: S
authors.initials: S
authors.lastname: Okada
mesh_terms: D000818:Animals; D001358:Avian Sarcoma Viruses / Q000235:genetics; D002478:Cells, Cultured; D018076:DNA, Complementary / Q000008:administration & dosage*; D004337:Drug Carriers; D016189:Dystrophin / Q000096:biosynthesis* / Q000235:genetics; D017930:Genes, Reporter; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors; D006801:Humans; D007763:Lac Operon; D009052:Leukemia Virus, Murine / Q000235:genetics; D008081:Liposomes; D051379:Mice; D018101:Mice, Inbred mdx; D018482:Muscle, Skeletal / Q000378:metabolism*; D009137:Muscular Dystrophy, Animal / Q000628:therapy*; D011401:Promoter Regions, Genetic
chemical_list: D018076:DNA, Complementary; D004337:Drug Carriers; D016189:Dystrophin; D008081:Liposomes